McIlrath & Eck’s Teladoc Health TDOC Stock Holding History

McIlrath & Eck’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$550	Hold	101	–	–	﹤0.01%	1514
2025 Q4	$707	Hold	101	–	–	﹤0.01%	940
2025 Q3	$781	Hold	101	–	–	﹤0.01%	900
2025 Q2	$880	Hold	101	–	–	﹤0.01%	881
2025 Q1	$804	Hold	101	–	–	﹤0.01%	880
2024 Q4	$918	Sell	101 -18	-15%	-$174	﹤0.01%	914
2024 Q3	$1.09K	Hold	119	–	–	﹤0.01%	900
2024 Q2	$1.16K	Hold	119	–	–	﹤0.01%	865
2024 Q1	$1.8K	Hold	119	–	–	﹤0.01%	826
2023 Q4	$2.56K	Buy	119 +1	+0.8%	+$18	﹤0.01%	782
2023 Q3	$2.19K	Hold	118	–	–	﹤0.01%	763
2023 Q2	$2.99K	Buy	118 +29	+33%	+$730	﹤0.01%	751
2023 Q1	$2.31K	Buy	89 +71	+394%	+$1.9K	﹤0.01%	765
2022 Q4	$426	Hold	18	–	–	﹤0.01%	835
2022 Q3	$0	Hold	18	–	–	﹤0.01%	897
2022 Q2	$1K	Hold	18	–	–	﹤0.01%	800
2022 Q1	$1K	Sell	18 -1	-5%	-$72	﹤0.01%	787
2021 Q4	$2K	Hold	19	–	–	﹤0.01%	733
2021 Q3	$2K	Hold	19	–	–	﹤0.01%	735
2021 Q2	$3K	Hold	19	–	–	﹤0.01%	702
2021 Q1	$3K	Buy	19 +18	+1,800%	+$4.17K	﹤0.01%	671
2020 Q4	$0	Hold	1	–	–	﹤0.01%	709
2020 Q3	$0	Hold	1	–	–	﹤0.01%	714
2020 Q2	$0	Buy	+1	New	+$175	﹤0.01%	722

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

McIlrath & Eck's TDOC Position: Q1 2026 in Review

McIlrath & Eck held its Teladoc Health (TDOC) position steady in Q1 2026 at 101 shares worth $550. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

McIlrath & Eck first reported a position in TDOC in Q2 2020 and has held it in 24 quarters since. The position peaked at $3K in Q2 2021. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

McIlrath & Eck held 101 shares of Teladoc Health worth $550 as of Q1 2026.
McIlrath & Eck left its Teladoc Health share count unchanged in Q1 2026.
Teladoc Health made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1514 holding.
McIlrath & Eck first reported a position in Teladoc Health in Q2 2020 and has held it in 24 quarters since.
McIlrath & Eck's Teladoc Health position peaked at $3K in Q2 2021.
325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.